Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063225
Filing Date
2023-11-14
Accepted
2023-11-13 18:52:44
Documents
93
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q emma-20230930.htm   iXBRL 10-Q 3558076
2 EX-4.1 emma-ex4_1.htm EX-4.1 118141
3 EX-10.1 emma-ex10_1.htm EX-10.1 34693
4 EX-10.2 emma-ex10_2.htm EX-10.2 443648
5 EX-10.3 emma-ex10_3.htm EX-10.3 641415
6 EX-31.1 emma-ex31_1.htm EX-31.1 15044
7 EX-31.2 emma-ex31_2.htm EX-31.2 12876
8 EX-32.1 emma-ex32_1.htm EX-32.1 15523
9 GRAPHIC img109337448_0.jpg GRAPHIC 5197
10 GRAPHIC img110260969_0.jpg GRAPHIC 835
11 GRAPHIC img110260969_1.jpg GRAPHIC 835
12 GRAPHIC img110260969_2.jpg GRAPHIC 835
13 GRAPHIC img110260969_3.jpg GRAPHIC 835
14 GRAPHIC img110260969_4.jpg GRAPHIC 835
15 GRAPHIC img110260969_5.jpg GRAPHIC 835
16 GRAPHIC img110260969_6.jpg GRAPHIC 988
17 GRAPHIC img111184490_0.jpg GRAPHIC 9638
18 GRAPHIC img111184490_1.jpg GRAPHIC 9638
19 GRAPHIC img111184490_2.jpg GRAPHIC 9638
  Complete submission text file 0000950170-23-063225.txt   17912292

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT emma-20230930_pre.xml EX-101.PRE 475305
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT emma-20230930_lab.xml EX-101.LAB 635211
22 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT emma-20230930_def.xml EX-101.DEF 327548
23 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT emma-20230930_cal.xml EX-101.CAL 65839
24 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT emma-20230930.xsd EX-101.SCH 85167
87 EXTRACTED XBRL INSTANCE DOCUMENT emma-20230930_htm.xml XML 4328495
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 231400778
SIC: 2834 Pharmaceutical Preparations